Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28708481.
- Also identified by DOI 10.3949/ccjm.84.s1.05.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antiobesity medications can improve metabolic control for patients with type 2 diabetes mellitus (DM) and obesity, but are underutilized. In this review, we describe the role of antiobesity drugs in the context of medically supervised and comprehensive weight-loss interventions and propose a pragmatic therapeutic algorithm for patients with type 2 DM and obesity that incorporates the use of antiobesity drugs early in the course of management.
Medical subject headings
- Anti-Obesity Agents
- Diabetes Mellitus, Type 2
- Obesity